653A9384.JPG

Turning wild-type lysins into drug-grade ε²Lysins

What makes PhagoMed’s ε²Lysins special?

  • In-silico discovery based on proprietary algorithms

  • Directed recombination of natural lysins using the ε² Platform

  • Optimized for potency, stability and manufacturing yield

  • Highly bactericidal & highly precise

  • Broad patent protection secured

Natural endolysins recombined to create endolysin with superior phenotype 

Natural lysin 1

Natural lysin 2

ε²Lysin

Recombinations

PhagoMed Biopharma GmbH

Leberstraße 20

1110 Vienna

Austria

contact@phagomed.com

Imprint & Privacy Policy